Literature DB >> 7523974

Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis.

A Migheli1, A Attanasio, D Schiffer.   

Abstract

Cytoskeletal abnormalities are a prominent pathological feature of anterior horn cells in amyotrophic lateral sclerosis (ALS), and are thought to be involved in the process of motor neuron death. Skein-like filamentous inclusions have been detected by immunocytochemical staining for ubiquitin, a stress protein involved in targeting abnormal proteins for proteolysis. So far, identification of the target protein has been elusive. We have studied the ultrastructural localization of ubiquitin and neurofilaments by post-embedding immunogold staining. In skein-like arrays, strong ubiquitin labelling was concentrated on abnormally formed 15-20 nm filaments; neurofilament labelling was localized on 10 nm filaments adjacent or in continuity with the abnormal filaments. In addition, Bunina bodies were a major site of ubiquitin accumulation. Our results suggest that ubiquitinated filaments in skein-like inclusions might originate from abnormally aggregated neurofilament proteins, which are no longer recognized by antibodies to neurofilament epitopes. Furthermore, the presence of ubiquitin in Bunina bodies suggests that, in addition to its protective role, ubiquitin might be directly implicated in the mechanism of programmed neuronal death in ALS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523974     DOI: 10.1111/j.1365-2990.1994.tb00970.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

1.  Reversibility of neurofilamentous inclusion formation following repeated sublethal intracisternal inoculums of AlCl3 in New Zealand white rabbits.

Authors:  M J Strong; S Gaytan-Garcia; D M Jakowec
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis.

Authors:  Srikanth Ranganathan; Robert Bowser
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

Authors:  R M Posmantur; X Zhao; A Kampfl; G L Clifton; R L Hayes
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

4.  Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.

Authors:  S M Chou; H S Wang; A Taniguchi; R Bucala
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

5.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.

Authors:  Xuejiao Sun; Jianyuan Song; Hailong Huang; Hong Chen; Kun Qian
Journal:  Stem Cell Res Ther       Date:  2018-11-15       Impact factor: 6.832

Review 7.  Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.

Authors:  Stefano Thellung; Alessandro Corsaro; Irene Dellacasagrande; Mario Nizzari; Martina Zambito; Tullio Florio
Journal:  Front Neurosci       Date:  2022-09-06       Impact factor: 5.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.